Presentation is loading. Please wait.

Presentation is loading. Please wait.

DECREASING HOSPITAL ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) THROUGH ACTIVE SURVEILLANCE Confidential: For Quality Improvement Purposes.

Published byDamian Ward Modified over 8 years ago

Similar presentations

Presentation on theme: "DECREASING HOSPITAL ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) THROUGH ACTIVE SURVEILLANCE Confidential: For Quality Improvement Purposes."— Presentation transcript:

1 DECREASING HOSPITAL ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) THROUGH ACTIVE SURVEILLANCE Confidential: For Quality Improvement Purposes Only

2 TEAM MEMBERS INFECTION CONTROL MICROBIOLOGY NURSING ADMINISTRATION
Jorge Parada MD,MPH Janis Bartel Alexander Tomich Emie Pua Gigi Marinakos-Trulis MICROBIOLOGY Paul Schreckenberger, PhD Sandy Chakonas Colleen Jarosz NURSING ADMINISTRATION Paula Hindle Sue Flores Vada Grant PEDIATRIC INFECTIOUS DISEASES Malliswari Challipalli MD Andrew Bonwit MD INFORMATION TECHNOLOGY Laura Digangi Julie Glen Connie Giere Media John Griffin The nurses who collected the MRSA screens and made this program possible Confidential: For Quality Improvement Purposes Only

3 Background The incidence of MRSA colonization and infections is increasing annually. MRSA is associated with serious infections, increase hospital length of stay, patient morbidity and mortality, as well as increased cost of hospitalization. In August, 2007 Illinois law mandated active surveillance for all ICU patients as well as all high risk non-ICU patients Magnet Forces of Magnetism - Force 7,Quality Improvement: “The organization has structures and processes for the measurement of quality and programs for improving the quality of care and services within the organization” Confidential: For Quality Improvement Purposes Only

4 Project Aim Statement A multidisciplinary task force developed a program to screen ALL inpatients for MRSA upon admission (for the purpose of identifying them early), isolating them appropriately, and thereby limiting hospital associated MRSA transmission and infection. The goal was to decrease the incidence of hospital acquired MRSA. Confidential: For Quality Improvement Purposes Only

5 Prior Pilot Interventions
Neonatal Intensive Care Unit (NICU) initiated active surveillance for all births, transfers in, and biweekly surveillance - January, 2005 Surgical Intensive Care Unit (SICU) initiated screening on admission and weekly surveillance for select patient populations (stay greater than 7 days, on ventilator greater than 5 days, dialysis) - June, 2005 Confidential: For Quality Improvement Purposes Only

6 Pilot Interventions: SICU Rates from 3.7 → 0.7 75% REDUCTION
SUSTAINED OVER TIME Confidential: For Quality Improvement Purposes Only

7 Solutions Implemented
Plan: UNIVERSAL SCREENING of ALL INPATIENTS MRSA Guidelines written, distributed and available on Loyola intranet under Policies Details screening process Decolonization treatment regimen outlined PCR rapid testing machine - decreased testing time from 48 → 2 hours Videotape on MRSA education purchased Original Loyola video developed outlining MRSA screening (from specimen collection, through lab processing to results reported) February,2008 Confidential: For Quality Improvement Purposes Only

8 Solutions Implemented - Timeline
October 15, 2007: All ICU patients screened November 27, 2007: All hospitalized patients screened March 4th, 2008: Pre-op screening for elective surgery (PAT/SAC) Additional Infectious Disease Clinics:January,2008 Confidential: For Quality Improvement Purposes Only

9 Infection Control MRSA Program
Nursing Grand Rounds on MRSA Surgical Grand Rounds on MRSA Nurse Managers meeting on MRSA Multiple MRSA-focused in-services, memos Loyola Patient/Family MRSA Informational Brochures developed and now available on Loyola intranet visa Employee Resources Loyola MRSA Educational Video for staff MRSA Guidelines available on Loyola intranet CD demonstrating technique for collection of MRSA nasal swab/screen Confidential: For Quality Improvement Purposes Only

10 Results INPATIENT: PREADMISSION TESTING
Number of screens performed (Nov 27th-May 1st) >10,000 which is 88% of admissions Number of positive screens (7%) PREADMISSION TESTING Number of screens performed (March 4th-May 1st) 1168 Number positive screens (4%) Confidential: For Quality Improvement Purposes Only

11 68% Universal MRSA Screening ICU MRSA Screening 0.5294 REDUCTION IN
(all patients admitted to hospital) ICU MRSA Screening (all patients admitted to ICU) 6-Month pre-surveillance rate 0.5294 68% REDUCTION IN NOSOCOMIAL MRSA RATES ICU surveillance rate 0.3924 Universal surveillance rate 0.1713 Confidential: For Quality Improvement Purposes Only

12 Next Steps Emergency Department MRSA screening for all hospital admissions Continued emphasis on prevention of infection: Hand washing, Appropriate isolation and cohorting of patients Environmental cleaning Decolonization of MRSA carriers Confidential: For Quality Improvement Purposes Only

Download ppt "DECREASING HOSPITAL ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) THROUGH ACTIVE SURVEILLANCE Confidential: For Quality Improvement Purposes."

Similar presentations

NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS

NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Infection Prevention and Control Jo Lickiss Nurse Consultant Infection Prevention and Control.

Infection Prevention and Control Jo Lickiss Nurse Consultant Infection Prevention and Control.
Performance Improvement Leadership Develop Program

Performance Improvement Leadership Develop Program
HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.

HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.
1 Eradicating MRSA and MSSA Prior to Inpatient Orthopedic Surgery Maureen Spencer, RN,M.Ed., CIC Infection Control Manager Diane Gulczynski, RN, MS, CNOR.

1 Eradicating MRSA and MSSA Prior to Inpatient Orthopedic Surgery Maureen Spencer, RN,M.Ed., CIC Infection Control Manager Diane Gulczynski, RN, MS, CNOR.
The call The happy years The awakening Work to do Michelle Bushey, RN, BS, BSN, CIC Director Infection Prevention and Patient Safety.

The call The happy years The awakening Work to do Michelle Bushey, RN, BS, BSN, CIC Director Infection Prevention and Patient Safety.
There are no financial disclosures by any members of this project.

There are no financial disclosures by any members of this project.
Team Members The Outstanding NICU Nursing Staff

Team Members The Outstanding NICU Nursing Staff
REALM project update MRSA and KPC January 26, 2011 Michael Lin, MD MPH on behalf of REALM co-investigators.

REALM project update MRSA and KPC January 26, 2011 Michael Lin, MD MPH on behalf of REALM co-investigators.
Multidisciplinary Task Force Cdiff Project Infection Preventionist Administration Environmental Services Personnel Registered Nurses Physicians Pharmacy.

Multidisciplinary Task Force Cdiff Project Infection Preventionist Administration Environmental Services Personnel Registered Nurses Physicians Pharmacy.
Current Challenges in the ICU Prof Craig Williams Institute of Healthcare Associated Infection UWS.

Current Challenges in the ICU Prof Craig Williams Institute of Healthcare Associated Infection UWS.
LOYOLA UNIVERSITY HEALTH SYSTEM Loyola University Chicago ProfessionalDevelopmentProfessionalDevelopment ClinicalPracticeClinicalPractice EvidenceBasedPracticeEvidenceBasedPractice.

LOYOLA UNIVERSITY HEALTH SYSTEM Loyola University Chicago ProfessionalDevelopmentProfessionalDevelopment ClinicalPracticeClinicalPractice EvidenceBasedPracticeEvidenceBasedPractice.
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.

Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
Ebola Facts October 15, 2014.

Ebola Facts October 15, 2014.
Preventing Transmission of MRSA in the Hospital Setting Patricia A. Pearson RN, CIC Infection Prevention & Control Synergy / St. Joseph’s Hospital.

Preventing Transmission of MRSA in the Hospital Setting Patricia A. Pearson RN, CIC Infection Prevention & Control Synergy / St. Joseph’s Hospital.
1 Eliminating MRSA Infections Plexus MRSA Bundle:The HOW of Staff Engagement and Culture Change.

1 Eliminating MRSA Infections Plexus MRSA Bundle:The HOW of Staff Engagement and Culture Change.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.

MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
Epidemiology and Control of Methicillin-Resistant Staphylococcus aureus in hospitals Maria Kapi,MD Registrar of Medical Microbiology Laiko General Hospital.

Epidemiology and Control of Methicillin-Resistant Staphylococcus aureus in hospitals Maria Kapi,MD Registrar of Medical Microbiology Laiko General Hospital.
BIOHAZARDOUS WASTE REDUCTION IN THE OPERATING ROOM OR QUALITY COUNCIL OR MANAGEMENT OR SURGICAL SERVICE TECHS ALL OR STAFF PP&G PURCHASING DEPARTMENT Confidential:

BIOHAZARDOUS WASTE REDUCTION IN THE OPERATING ROOM OR QUALITY COUNCIL OR MANAGEMENT OR SURGICAL SERVICE TECHS ALL OR STAFF PP&G PURCHASING DEPARTMENT Confidential:
1 st European S. aureus & Surgical Site Infection Round Table MRSA Prescreening and Elimination: New England Baptist Hospital Experience Vienna, Austria.

1 st European S. aureus & Surgical Site Infection Round Table MRSA Prescreening and Elimination: New England Baptist Hospital Experience Vienna, Austria.

Similar presentations

Ads by Google